|Your personal background.|
|The development comes on the heels of PharmEasy elevating $350 Mn from |
Singapore’s Amansa Capital, Blackstone-backed
ApaH Capital, Janus Henderson, Orbimed, Steadview Capital, Buy tadalis sx online and ADQ.
The investment could possibly be seen as a pre-IPO round that the startup was
in talks to boost for someday now earlier than filing its draft
pink herring prospectus. Based in 2015 by Sheth and Buy Dofil
online Shah, Buy Nicoazolin online PharmEasy merged
with its investor entity, Ascent Health, to type API Holdings in 2019 and
onboarded three cofounders - Siddharth Shah, Hardik Dedhia, and Harsh Parekh.
India. The startup offers SaaS procurement options, delivery and logistics
assist, and Buy Lamican online credit score solutions to pharmacies.
The startup claims to have served over 20 Mn patients since inception. Multiple media studies
recommend that PharmEasy is more likely to file its prospectus which incorporates details about its IPO supply with the market regulator
by the tip of this month. The startup is eyeing a
$1 Bn IPO, an amount just like what hospitality unicorn OYO is making an attempt to boost
from the general public market. In September, the startup appointed five independent directors
- Vineeta Rai, Subramanian Somasundaram, Buy tadalis
sx online Dr Jaydeep Tank, Ramakant Sharma and Deepak
Vaidya. Last month, PharmEasy acquired a majority stake in healthcare provide chain startup Aknamed for INR 307 Cr.
Earlier this year, it also acquired 66% stake in diagnostic chain Thyrocare for
INC 4,546 Cr. Buy tadalis sx online
|Your feedback on this profile|
|Recommend this profile for User of the Day:
||I like this profile
|Alert administrators to an offensive profile:
||I do not like this profile